By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.

Medicine

A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.

Last updated: May 3, 2026 8:23 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A new study shows that blocking the IL-1β signaling pathway in the brain can halt the damaging inflammation that drives neuromyelitis optica (NMO), a severe autoimmune disease. Researchers found that using an antisense oligonucleotide (ASO) to lower IL-1β levels protected nerve cells and improved movement in mice, offering a promising new treatment approach for this condition.
Source →

•
A cutting-edge study used single-cell proteomics to discover that eggs from mice lacking the Patl2 gene have severe protein defects, leading to infertility. Remarkably, scientists were able to rescue these eggs and restore their ability to develop into healthy embryos by transferring their genetic material into a healthy egg cell, a technique known as spindle transfer.
Source →

•
New research on the H5N1 bird flu virus reveals that modern strains can replicate efficiently in a lab-grown model of the human nose. This finding raises important concerns about the virus’s potential to adapt to humans and the need for continued monitoring of its spread.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Diabetes Science Briefing | May 3rd 2026, 10:10:16 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Data Model Dilemma: How Your Database Choice Shapes Real-World Evidence in Immunology and Pharmacology

A Global Milestone: Cholera Prevention Campaigns Restart After Three-Year Hiatus

Today’s Clinical Medicine Science Briefing | April 14th 2026, 9:00:12 am

A Genetic Key to Drug-Induced Uric Acid Changes

The beverage quality index: A new sip for diabetes risk prediction

This weeks’ Key Highlights of Infectious Diseases science

This week’s Medicine Key Highlights

A New Frontier in Heart Failure: The 2025 CPIC Guideline for Thiopurine Pharmacogenetics

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Energy
  • Natural Language Processing
  • Chemistry
  • Neurology
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?